Literature DB >> 22692466

Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography.

Hyun Woo Chung1, Sun-Young Lee, Hye Seung Han, Hyun Sik Park, Jae Hoon Yang, Hak Hyun Lee, Young So.   

Abstract

BACKGROUND: Gastric cancers exhibit various degrees of (18)F-fluorodeoxyglucose (FDG) uptakes on positron emission tomography/computed tomography (PET/CT) imaging. The aim of this study was to evaluate whether FDG uptake in gastric cancer varies according to the microsatellite instability (MSI) status.
METHODS: Consecutive gastric cancer patients who underwent PET/CT imaging and MSI analysis were included in the study. The maximum standardized uptake value (SUVmax) of gastric cancer was assessed using PET/CT imaging.
RESULTS: Of 131 gastric cancers, 16 exhibited a high incidence of MSI (MSI-H) and 3 exhibited a low incidence of MSI (MSI-L). In 29 subjects who showed no uptake on PET/CT imaging the gastric cancers were all microsatellite stable (MSS). Gastric cancers with MSI were related to age older than 60 years (p = 0.002), cancer volume larger than 10 cm(3) (p = 0.015), and the presence of FDG uptake on PET/CT imaging (p = 0.001). A higher SUVmax of gastric cancer was linked to the presence of MSI (p < 0.001).
CONCLUSION: The presence of MSI is related to FDG uptake in gastric cancer. Care should be taken with MSS gastric cancers, because they show lower SUVmax on PET/CT imaging than MSI gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692466     DOI: 10.1007/s10120-012-0165-2

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  27 in total

1.  Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis.

Authors:  May-Britt Tessem; Kirsten M Selnaes; Wenche Sjursen; Gerd Tranø; Guro F Giskeødegård; Tone F Bathen; Ingrid S Gribbestad; Eva Hofsli
Journal:  J Proteome Res       Date:  2010-07-02       Impact factor: 4.466

Review 2.  Cancer of the microsatellite mutator phenotype.

Authors:  M Perucho
Journal:  Biol Chem       Date:  1996-11       Impact factor: 3.915

3.  Correlation between microsatellite instability and metachronous disease recurrence after endoscopic mucosal resection in patients with early stage gastric carcinoma.

Authors:  A Kawamura; K Adachi; S Ishihara; T Katsube; T Takashima; M Yuki; K Amano; R Fukuda; Y Yamashita; Y Kinoshita
Journal:  Cancer       Date:  2001-01-15       Impact factor: 6.860

4.  High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma.

Authors:  Hyun Woo Chung; Eun Jeong Lee; Yo-Han Cho; So Young Yoon; Young So; Sung-Yong Kim; Mark Hong Lee; Jeong Hwan Kim; Sun-Young Lee; In-Kyung Sung; Hyung-Seok Park; Moon-Won Yoo; Kyung-Yung Lee
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-20       Impact factor: 4.553

Review 5.  Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Authors:  Hideaki Shimada; Shinichi Okazumi; Masamichi Koyama; Koji Murakami
Journal:  Gastric Cancer       Date:  2011-02-18       Impact factor: 7.370

Review 6.  Mammalian DNA mismatch repair.

Authors:  A B Buermeyer; S M Deschênes; S M Baker; R M Liskay
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

7.  Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.

Authors:  Seok-Ki Kim; Keon Wook Kang; Jong Seok Lee; Hark Kyun Kim; Hee Jin Chang; Jin Yi Choi; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim; Jae-Moon Bae
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-15       Impact factor: 9.236

8.  Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.

Authors:  Katja Ott; Ken Herrmann; Florian Lordick; Hinrich Wieder; Wolfgang A Weber; Karen Becker; Andreas K Buck; Martin Dobritz; Ulrich Fink; Kurt Ulm; Tibor Schuster; Markus Schwaiger; Jörg-Rüdiger Siewert; Bernd J Krause
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

9.  Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer.

Authors:  H C Wirtz; W Müller; T Noguchi; M Scheven; J Rüschoff; G Hommel; H E Gabbert
Journal:  Clin Cancer Res       Date:  1998-07       Impact factor: 12.531

10.  High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients.

Authors:  Won Hyuk Choe; Sun-Young Lee; Jun Haeng Lee; Sang Goon Shim; Young-Ho Kim; Poong-Lyul Rhee; Jong Chul Rhee; Chang-Seok Ki; Jong-Won Kim; Sang Yong Song; Jae J Kim
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

View more
  9 in total

1.  How can research fields be integrated with PET imaging?

Authors:  Haruhiko Sugimura
Journal:  Gastric Cancer       Date:  2013-04       Impact factor: 7.370

Review 2.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

3.  The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer.

Authors:  Jingjun Wu; Yue Lv; Nan Wang; Ying Zhao; Pengxin Zhang; Yijun Liu; Anliang Chen; Jianying Li; Xin Li; Yan Guo; Tingfan Wu; Ailian Liu
Journal:  Eur Radiol       Date:  2019-03-22       Impact factor: 5.315

4.  Microsatellite Instability of Gastric and Colorectal Cancers as a Predictor of Synchronous Gastric or Colorectal Neoplasms.

Authors:  Young Beak Kim; Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Hye Seung Han
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

5.  BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status.

Authors:  Min Hye Jang; Sehun Kim; Dae Yong Hwang; Wook Youn Kim; So Dug Lim; Wan Seop Kim; Tea Sook Hwang; Hye Seung Han
Journal:  J Korean Med Sci       Date:  2017-01       Impact factor: 2.153

6.  Metabolic activity via 18F-FDG PET/CT is predictive of microsatellite instability status in colorectal cancer.

Authors:  Jinling Song; Zhongwu Li; Lujing Yang; Maomao Wei; Zhi Yang; Xuejuan Wang
Journal:  BMC Cancer       Date:  2022-07-22       Impact factor: 4.638

7.  Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma.

Authors:  Bo Hu; Chao Qu; Wei-Jun Qi; Cheng-Hao Liu; Dian-Rong Xiu
Journal:  Front Genet       Date:  2022-10-04       Impact factor: 4.772

8.  Effect of FOLFOX4 combined with Brucea javanica emulsion on VEGF in patients with gastric cancer.

Authors:  Zheng Chen; Zhenyu Zhou; Zhigang Hu; Qiaodong Xu; Jie Wang
Journal:  Oncol Lett       Date:  2017-11-16       Impact factor: 2.967

9.  Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics.

Authors:  Jiaru Li; Ziyi Yang; Bowen Xin; Yichao Hao; Lisheng Wang; Shaoli Song; Junyan Xu; Xiuying Wang
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.